Generating human podocyte cells
AssigneeThe Cleveland Clinic Foundation
InventorsOliver Wessely, Uyen Wessely, Jan Jensen, Michael Bukys
Life of this patent
Estimating the term…
Abstract
Provided herein are compositions, systems, kits, and methods for generating human podocyte cells by contacting human nephron progenitor cells with an FGFR pathway inhibitor, a BMP pathway inhibitor, and a WNT pathway inhibitor. In certain embodiments, the nephron progenitor cells are further contacted with at least one factor selected from: BMP4, BMP7, lysophosphatidic acid, and gamma-secretase inhibitor XX. In certain embodiments, the contacting the nephron progenitor cells is performed under serum-free conditions.
Claims12
A method of generating podocyte cells comprising:
- a) contacting a population of nephron progenitor cells with an FGFR pathway inhibitor, a BMP pathway inhibitor, a γ secretase inhibitor BMP4, BMP7, and a WNT pathway inhibitor;
- and
- b) culturing at least a portion of said population of nephron progenitor cells such that a population of podocyte cells is generated.
Dependencies are inferred from the claim text.